Page last updated: 2024-11-12

flustramine c

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

flustramine C: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10041611
CHEMBL ID524353
MeSH IDM0499735

Synonyms (3)

Synonym
flustramine c
CHEMBL524353
(8br)-6-bromo-3-methyl-8b-(2-methylbut-3-en-2-yl)-1,2-dihydropyrrolo[2,3-b]indole
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID397820Blockade of voltage-activated rat brain Nav1.2 sodium channel type 2 channel expressed in Xenopus laevis oocytes assessed as effect on evoked current by two-electrode voltage clamp method2002Journal of natural products, Nov, Volume: 65, Issue:11
Four new bromotryptamine derivatives from the marine bryozoan Flustra foliacea.
AID397819Blockade of voltage-activated rat Kv1.4 potassium channel expressed in Xenopus laevis oocytes assessed as effect on evoked current upto 10 uM by two-electrode voltage clamp method2002Journal of natural products, Nov, Volume: 65, Issue:11
Four new bromotryptamine derivatives from the marine bryozoan Flustra foliacea.
AID397818Blockade of voltage-activated rat Kv1.1 potassium channel expressed in Xenopus laevis oocytes assessed as effect on evoked current upto 10 uM by two-electrode voltage clamp method2002Journal of natural products, Nov, Volume: 65, Issue:11
Four new bromotryptamine derivatives from the marine bryozoan Flustra foliacea.
AID1858699Antibiofilm activity against Acinetobacter baumannii ATCC 19606 assessed as inhibition of biofilm formation at 100 uM incubated for 24 hrs by crystal violet method relative to control2021European journal of medicinal chemistry, Jan-01, Volume: 209Tryptophan derived natural marine alkaloids and synthetic derivatives as promising antimicrobial agents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's1 (16.67)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (16.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]